Business Segments · Goodwill

MedSurg and Neurotechnology: — Goodwill

Stryker MedSurg and Neurotechnology: — Goodwill decreased by 4.9% to $11.95B in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026
Rolls up toGoodwill

How to read this metric

High levels suggest significant historical M&A activity, while sudden decreases may signal impairment charges due to underperforming acquisitions.

Detailed definition

Reflects the intangible asset value recorded when the cost of acquiring businesses within the MedSurg and Neurotechnolog...

Peer comparison

Standard across large-cap medical device companies that utilize M&A as a growth strategy.

Metric ID: syk_segment_medsurg_and_neurotechnology_goodwill

Historical Data

7 periods
 Q4 '21Q4 '22Q4 '23Q3 '24Q4 '24Q4 '25Q1 '26
Value$5.67B$7.94B$8.27B$528.00M$9.21B$12.56B$11.95B
QoQ Change+40.0%+4.2%-93.6%>999%+36.4%-4.9%
YoY Change+40.0%+4.2%+11.3%+36.4%
Range$528.00M$12.56B
CAGR+64.4%
Avg YoY Growth+23.0%
Median YoY Growth+23.9%

Frequently Asked Questions

What is Stryker's medsurg and neurotechnology: — goodwill?
Stryker (SYK) reported medsurg and neurotechnology: — goodwill of $11.95B in Q1 2026.
What does medsurg and neurotechnology: — goodwill mean?
The value of intangible assets like brand and synergy acquired through business purchases within this segment.